News | Radiology Imaging | July 22, 2015

ViewRay's MRIdian System Featured at AAPM 2015

Users presented on online adaptive and real-time motion tracking with MRI-guided radiation therapy

July 22, 2015 - ViewRay's MRIdian System, the world's first and only magnetic resonance imaging (MRI)-guided radiation therapy system, was featured during the 2015 annual meeting of the American Association of Physicists in Medicine (AAPM). This year's meeting was held July 12-16 in Anaheim, California.

The MRIdian System is designed to improve the accuracy of cancer treatments through a patented combination of simultaneous MRI and radiation therapy delivery. With continuous soft-tissue imaging, clinicians can clearly see the cancer target, monitor where the actual radiation dose is being delivered, and adapt to changes in the patient's anatomy – all in real time while the patient is on the treatment table. This provides a more precise and personalized cancer treatment.

AAPM selected 20 abstracts reporting on real-world clinical experience with MR-guided radiation therapy from three MRIdian sites. These oral and poster presentations included the "Best in Physics" presentation: An Integrated Model-Based Intrafractional Organ Motion Tracking Approach with Dynamic MRI in Head and Neck Radiotherapy. The presentations covered a wide range of topics including on-table adaptive treatments, real-time MR motion tracking, online Monte Carlo dose calculations and several relating to system quality assurance.

Additionally, a number of physicist users of the MRIdian System presented on their experience in ViewRay's booth. Clinical applications experts from ViewRay were also available in the booth to demonstrate treatment planning and delivery functionality of the system.

For more information: www.viewray.com

Related Content

MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Machine Learning Uncovers New Insights Into Human Brain Through fMRI
News | Neuro Imaging | January 11, 2019
An interdisciplinary research team led by scientists from the National University of Singapore (NUS) has successfully...
Hypertension With Progressive Cerebral Small Vessel Disease Increases Cognitive Impairment Risk
News | Magnetic Resonance Imaging (MRI) | January 08, 2019
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
First Arterial and Venous Atlas of the Human Brain Released
News | Neuro Imaging | January 02, 2019
January 2, 2019 — Imagine an atlas containing an image bank of the blood vessels of the...
MRI Effective for Monitoring Liver Fat in Obese Patients
News | Magnetic Resonance Imaging (MRI) | December 28, 2018
Magnetic resonance imaging (MRI) provides a safe, noninvasive way to monitor liver fat levels in people who undergo...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
FDA Approves Exablate Neuro for Tremor-Dominant Parkinson's Treatment
Technology | Focused Ultrasound Therapy | December 21, 2018
Insightec announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication of...